J Keith-Rokosh1, L C Ang. 1. Department of Pathology, London Health Sciences Centre and University of Western Ontario, London, Ontario, Canada.
Abstract
OBJECTIVES: The neuropathological findings of 32 progressive supranuclear palsy (PSP) cases over a period of 17 years were reviewed. RESULTS: Of the 26 cases with adequate clinical data, 20 patients either presented with cognitive dysfunction or developed a cognitive impairment subsequently during the course of the disease. Co-existing changes of argyrophilic grains and corticobasal degeneration (CBD) were found in 28% and 32% of the cases respectively. Alzheimer-related pathology was found in 69% of cases but only 18.75% of cases fulfilled the consortium to establish a registry for Alzheimer's disease (CERAD) criteria for either definite or probable Alzheimer's disease. Lewy bodies were noted in four cases (12.5%), all in the subcortical regions. Only seven cases of PSP showed no pathological evidence of other co-existing neurodegenerative diseases. The severity of the cerebrovascular pathology in this cohort was insufficient to explain any clinical symptomatology. CONCLUSIONS: As in previous studies, this study has demonstrated the frequent co-existence of pathological changes usually noted in other neurodegenerative diseases in PSP. Whether these co-existing pathological changes contribute to the cognitive impairment in PSP remains uncertain.
OBJECTIVES: The neuropathological findings of 32 progressive supranuclear palsy (PSP) cases over a period of 17 years were reviewed. RESULTS: Of the 26 cases with adequate clinical data, 20 patients either presented with cognitive dysfunction or developed a cognitive impairment subsequently during the course of the disease. Co-existing changes of argyrophilic grains and corticobasal degeneration (CBD) were found in 28% and 32% of the cases respectively. Alzheimer-related pathology was found in 69% of cases but only 18.75% of cases fulfilled the consortium to establish a registry for Alzheimer's disease (CERAD) criteria for either definite or probable Alzheimer's disease. Lewy bodies were noted in four cases (12.5%), all in the subcortical regions. Only seven cases of PSP showed no pathological evidence of other co-existing neurodegenerative diseases. The severity of the cerebrovascular pathology in this cohort was insufficient to explain any clinical symptomatology. CONCLUSIONS: As in previous studies, this study has demonstrated the frequent co-existence of pathological changes usually noted in other neurodegenerative diseases in PSP. Whether these co-existing pathological changes contribute to the cognitive impairment in PSP remains uncertain.
Authors: Virgilio Gerald H Evidente; Charles H Adler; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; John N Caviness; Lucia I Sue; Thomas G Beach Journal: Parkinsonism Relat Disord Date: 2011-03-21 Impact factor: 4.891
Authors: María Elena Erro Aguirre; María Victoria Zelaya; Javier Sánchez Ruiz de Gordoa; María Teresa Tuñón; José Luis Lanciego Journal: Front Neuroanat Date: 2015-03-11 Impact factor: 3.856
Authors: Karsten Mueller; Robert Jech; Cecilia Bonnet; Jaroslav Tintěra; Jaromir Hanuška; Harald E Möller; Klaus Fassbender; Albert Ludolph; Jan Kassubek; Markus Otto; Evžen Růžička; Matthias L Schroeter Journal: Front Neurosci Date: 2017-03-07 Impact factor: 4.677